Is Insight Enterprises the right stock to buy?
When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose... Insight Enterprises (NSIT) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices.
What does Insight Pharmaceuticals Corporation do?
INSIGHT Pharmaceuticals Corporation manufactures non-prescription medications for common ailments. The Company offers allergy tablets, sugar free sore throat and cough lozenges, nasal decongestants, sore throat, and cough lozenges products, as well as anti-itch creams, arthritis ointments, and lice treatment products.
How much of Insight Enterprises does Lamneck still own?
The total transaction amounted to $632,224. Lamneck still owns a total of 342,362 shares of Insight Enterprises worth, $36,215,052. Insight Enterprises shares are tra
See more
When is Insight keynote 2021?
TEMPE, Ariz., Jun 15, 2021--Insight Enterprises (NASDAQ:NSIT), the global integrator of Insight Intelligent Technology Solutions™ for organizations of all sizes, will host a virtual keynote event Thursday at 1:30 p.m. (EDT) on Charting a New Future: Healthcare Technology in a Post-Pandemic World.
What is NSIT 2021?
TEMPE, Ariz., August 12, 2021--Insight Enterprises (NASDAQ:NSIT), the global provider of Insight Intelligent Technology Solutions™ for organizations of all sizes, today announced a partnership with Women In Cloud, an economic development organization dedicated to advancing gender inclusion in technology, for the #WICxFortune100 Initiative.
About
INSIGHT Pharmaceuticals, LLC. is an innovative and fast–growing consumer products company.
Highlights
View contacts for Insight Pharmaceuticals to access new leads and connect with decision-makers.
Details
INSIGHT Pharmaceuticals, LLC. is an innovative and fast–growing consumer products company that is quietly transforming the over-the-counter (OTC) marketplace. We are a privately held company with an aggressive growth strategy built upon the acquisition of a recognizable set of OTC women’s health and personal care products.
M&A Details
Insight Pharmaceuticals was acquired by Prestige Brands Holdings for $750M on Apr 25, 2014. This deal was done in Cash.
What is Infinity Pharmaceuticals?
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) ("Infinity" or the "Company"), a clinical-stage biotechnology company developing eganelisib (IPI-549 ), a potentially first-in-class, oral, immuno-oncology macrophage reprogramming therapeutic, today announced its first quarter 2021 financial results and provided a corporate update.
When is Infinity conference call 2021?
(NASDAQ: INFI), a clinical-stage biotechnology company developing eganelisib, a potentially first-in-class, oral, immuno-oncology macrophage reprogramming therapeutic that addresses a fundamental biologic mechanism of immune suppression in cancer, will host a conference call on Thursday, May 13th 2021 at 4:30pm ET to report its financial results for the first quarter of 2021.
Is Infinity Pharmaceuticals a biotechnology company?
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI), a clinical-stage biotechnology company developing eganelisib, a potentially first-in-class, oral, immuno-oncology macrophage reprogramming therapeutic that addresses a fundamental biologic mechanism of immune suppression in cancer, today announced that the Company will have a presentation summarizing recent eganelisib clinical data will be followed by a Q&A session at the New York Academy of Sciences’ Frontiers in Cancer Immunotherapy 2021 virtual symposium taking place on May 12-14, 2021.
